-
463P A real-world study to evaluate biomarker testing and treatment management in patients with locally advanced unresectable or metastatic G/GEJ adenocarcinoma in France, Germany, Italy, Spain, UK and Canada: Adelphi Real World G/GEJ cancer disease specific programme
Florian Lordick, Emilse Roncancio‐Diaz, Katie Lewis, Annabel Lambert, Georgia N. Thomason, A. Van Oosten, +4 more
1citations -
108P Epigenetic regulation of the putative breast cancer metastasis suppressor gene SCN4B2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Epigenetics and DNA Methylation Open access
Lars Hilgers, Arndt Hartmann, Peter Andreas Fasching, Sophia Villwock, Lorna Moll, Sébastien Roger, +3 more
0citations -
28P EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
J. Leichsenring, Valentina A. Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, +14 more
0citations -
17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jenny Furlanetto, Carsten Denkert, Michael Untch, Bruno Valentin Sinn, Bianca Lederer, Andreas Schneeweiß, +9 more
0citations -
21P BACH1 and HIF1α predict response to neoadjuvant nab-paclitaxel (nP) treatment in early breast cancer (BC)2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Valentina A. Vladimirova, Andreas Schneeweiß, Christian Jackisch, Karsten Ernst Weber, Carsten Denkert, Sabine Schmatloch, +13 more
0citations -
218P Differential effects of estrogen exposure on steroid metabolizing CYP enzyme expression in estrogen receptor alpha versus beta positive breast cancer cell lines0citations
-
24P Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
B.V. Sinn, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, Katharina Sychra, +12 more
0citations -
187P Routine care of early breast cancer (stage I-III) in Germany: Data of the prospective, intersectoral research platform OPAL2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
A. Welt, M-O. Zahn, A. Wöckel, E. Stickeler, M. Thoma, Arnd Nusch, +11 more
0citations -
266P Association of RAD51 and efficacy outcomes in patients with HER2-negative breast cancer (BC) and homologous recombination deficiency (HRD): Post-hoc analysis of the GeparOla trial
Guillermo Javierre Villacampa, Natalie Filmann, P.A. Fasching, J. Balmaña, Thomas Karn, Federik Marme, +12 more
0citations -
1485P Atezolizumab plus bevacizumab before or after transarterial chemoembolization in hepatocellular carcinoma: Interim analysis of the DEMAND (AIO-HEP-0418) randomized phase II clinical trial2025 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Alexander B. Philipp, Najib Ben Khaled, Jens Ricke, Julia V. Mayerle, Dirk Waldschmidt, Ilja Kubisch, +12 more
0citations -
1192P Characterization of patients with newly diagnosed advanced ovarian cancer not receiving maintenance therapy: Results of a prospective real-world study (NOGGO ov54, SCOUT-1)
Pauline Wimberger, Elena Ioana Braicu, Klaus Pietzner, J. Goldmann, Karol Kubiak, Cosima V. M. Brucker, +14 more
0citations -
763P The influence of multidisciplinary team meetings on treatment decisions in muscle invasive bladder cancer: A nationwide study in the Netherlands
Janneke E. W. Walraven, Theodora M. Ripping, Jorg Reinier Oddens, Bas W.G. van Rhijn, Catharina A. Goossens‐Laan, Maarten C.C.M. Hulshof, +8 more
0citations -
1103P Long-term survival of real-world advanced melanoma patients treated with targeted therapy2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Rawa Kamaran Ismail, Anthonius de Boer, Maaike van Dartel, Doranne L. Hilarius, Michiel C.T. van Zeijl, F. Van Den Eertwegh, +14 more
0citations -
1626MO Treatment expectations and preferences for quality versus quantity of life in patients with advanced soft tissue sarcomas starting palliative 1st line chemotherapy
Eugenie Younger, Robin L. Jones, Dide den Hollander, Vicky L. M. N. Soomers, Ingrid M.E. Desar, Astrid W. Oosten, +5 more
0citations